The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication, and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org
CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.
Although the maternal mortality rate in Ghana has declined from 378 to 263 per 100,000 live births, neonatal mortality has also decreased from 31.8 per 1,000 live births in 2007 to 17 per 1,000 live births. An estimated 17 deaths per 1000 live births among newborns accounts for 48% of under-five deaths and 68% of infant deaths. However, Ghana's achievements still fall short of the Sustainable Development Goals (SDGs). Key drivers of maternal mortality from obstetric causes include haemorrhage (38.2%), hypertensive disorders (18.3%), sepsis (9.5%), and abortion (5.3%). The majority of newborn deaths result from prematurity (24%), complications during labour and delivery, such as birth asphyxia (24%), and infections like sepsis (18%).
The CHAI Ghana Sexual Reproductive, and Maternal Health (SRMNH) program is providing support to the Ministry of Health/Ghana Health Service (GHS) and other SRMH partners in their efforts to reduce the high incidence of maternal and newborn morbidity and mortality in Ghana. Through an FCDO-funded project, CHOICES, CHAI is assisting the MOH/GHS in scaling up new and lesser-used products for SRMH, as well as managing and treating postpartum hemorrhage and hypertension in pregnancy, including the introduction and scaling up of caffeine citrate in neonatal units within hospitals across the country. Through the BMGF Beginning Fund CHAI will support product introduction and market shaping efforts focused on prioritized MNCH health commodities and availability, quality, and use by identifying potential system-level opportunities for investment in market shaping and strategic procurement. An upcoming Unitaid Sustained Uptake of Products for Pre-Eclampsia and Maternal Anemia (SUPREME) grant will fund supply-side activities to support equitable access to diagnostic and therapeutic products for preeclampsia/eclampsia and anemia in Ghana.
CHAI seeks to strengthen market stewardship, including new product integration processes, through improved coordination, data analysis, monitoring, and research at both the national and sub-national levels, with technical assistance to the Ministry of Health and the Ghana Health Service to enhance commodity security and management for SRMNCH commodities.
The Program Manager (PM) will provide strategic leadership and coordination across CHAI Ghana programs involved in enhancing access to commodities for critical therapeutics and diagnostics, particularly in Reproductive, maternal, newborn, child, and adolescent health (RMNCAH). This role will essentially conceptualize CHAI Ghana’s strategy for Commodity Access, build the requisite technical expertise in this space, mobilize resources to grow the portfolio, and oversee workstreams spanning product introduction, market shaping, evidence generation, local manufacturing capacity assessment, market stewardship, and supply planning. The PM will lead grant operations, grant management, and donor reporting across portfolio investments. The Program Manager will serve as a key liaison with the Ministry of Health, the Ghana Health Service, Christian Health Association of Ghana, the Pharmaceutical Manufacturers and Suppliers Groups, Food and Drugs Authority, and other relevant agencies. He will also provide technical oversight in scaling up local manufacturing of health products.
Thought Leadership and Technical Oversight
Market Shaping
Financing and Fundraising
Education
Experience
Skills and Competencies
#jobreference3 #region4
Software Powered by iCIMS
www.icims.com